mTOR inhibitors, such as rapamycin and its analogs (rapalogs), are compounds that specifically inhibit mTOR activity. These inhibitors are used in clinical settings to treat cancers, autoimmune diseases, and to prevent organ transplant rejection. By inhibiting mTOR, these drugs can reduce cell proliferation, induce autophagy, and modulate immune responses.
